Effects of 5 alpha-reductase inhibition by finasteride on lipoproteins and body composition in males affected by benign prostatic hyperplasia (BPH)

J Endocrinol Invest. 1999;22(10 Suppl):70-1.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Body Composition / drug effects*
  • Cholestenone 5 alpha-Reductase
  • Dihydrotestosterone / blood
  • Enzyme Inhibitors / therapeutic use*
  • Finasteride / therapeutic use*
  • Humans
  • Lipoproteins / blood*
  • Male
  • Middle Aged
  • Oxidoreductases / antagonists & inhibitors*
  • Prostatic Hyperplasia / blood
  • Prostatic Hyperplasia / drug therapy*
  • Prostatic Hyperplasia / enzymology*
  • Prostatic Hyperplasia / pathology*

Substances

  • Enzyme Inhibitors
  • Lipoproteins
  • Dihydrotestosterone
  • Finasteride
  • Oxidoreductases
  • Cholestenone 5 alpha-Reductase